REFERENCES
1. Lee W.W. Recent advances in nuclear cardiology. Nucl Med Mol Imaging. 2016; 50 (3): 196–206. DOI: https://doi.org/10.1007/s13139-016-0433-x
2. Rozanski A., Gransar H., Hayes S.W., Min J., Friedman J.D., Thomson L.E., et al. Temporal trends in the frequency of inducible myocardial ischemia during cardiac stress testing: 1991 to 2009. J Am Coll Cardiol. 2013; 61: 1054–65. DOI: https://doi.org/10.1016/j.jacc.2012.11.056
3. Garcia E.V., Slomka P., Moody J.B., Germano G., Ficaro E.P. Quantitative clinical nuclear cardiology, part 1: established applications. J Nucl Cardiol. 2020; 27 (1): 189–201. DOI: https://doi.org/10.1007/s12350-019-01906-6
4. Denisova N.V. Imaging in diagnostic nuclear medicine. Technical Physics 2018; 63 (9): 1375–83.
5. Denisova N. V., Terekhov I. N. A study of myocardial perfusion SPECT imaging with reduced radiation dose using maximum likelihood and entropy-based maximum a posteriori approaches. Biomed Phys Eng Express. 2016; 2 (5): 055015.
6. Denisova N. V., Ansheles A. A. A study of false apical defects in myocardial perfusion imaging with SPECT/CT. Biomed Phys Eng Express. 2018; 4 (6): 065018.
7. Kachurina E.N., Kokov A.N., Kareeva A.I., Barbarash O.L. Coronary artery calcification prevalence among residents of Western Syiberia: ESSE-RF study. Kompleksnye problemy serdechno-sosudistykh zabolevaniy [Complex Problems of Cardiovascular Diseases]. 2018; 7 (4): 33–40. DOI: https://doi.org/10.17802/2306-1278-2018-7-4-33-40 (in Russian)
8. Ong K.L., McClelland R.L., Rye K.A., Cheung B.M., Post W.S., Vaidya D., et al. The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2014; 236 (2): 257–62. DOI: https://doi.org/10.1016/j.atherosclerosis.2014.07.015
9. Arai A.E. The cardiac magnetic resonance (CMR) approach to assessing myocardial viability. J Nucl Cardiol. 2011c; 18 (6): 1095–102. DOI: https://doi.org/10.1007/s12350-011-9441-5
10. Brodov Y., Gransar H., Dey D., Shalev A., Germano G., Friedman J.D., et al. Combined quantitative assessment of myocardial perfusion and coronary artery calcium score by hybrid 82Rb PET/CT improves detection of coronary artery disease. J Nucl Med. 2015; 56: 1345–50. DOI: https://doi.org/10.2967/jnumed.114.153429
11. Liga R., Vontobel J., Rovai D., Marinelli M., Caselli C., Pietila M., et al. Multicentre multi-device hybrid imaging study of coronary artery disease: results from the EValuation of INtegrated Cardiac Imaging for the Detection and Characterization of Ischaemic Heart Disease (EVINCI) hybrid imaging population. Eur Heart J Cardiovasc Imaging. 2016; 17 (9): 951–60. DOI: https://doi.org/10.1093/ehjci/jew038
12. Bulluck H., White S.K., Frohlich G.M., Casson S.G., O’Meara C., Newton A., et al. Quantifying the area at risk in reperfused ST-segment-elevation myocardial infarction patients using hybrid cardiac positron emission tomography-magnetic resonance imaging. Circ Cardiovasc Imaging. 2016; 9: e003900. DOI: https://doi.org/10.1161/CIRCIMAGING.115.003900
13. Rischpler C., Dirschinger R.J., Nekolla S.G., Kossmann H., Nicolosi S., Hanus F., et al. Prospective evaluation of 18F-Fluorodeoxyglucose uptake in postischemic myocardium by simultaneous positron emission tomography/magnetic resonance imaging as a prognostic marker of functional outcome. Circ Cardiovasc Imaging. 2016; 9: e004316. DOI: https://doi.org/10.1161/CIRCIMAGING.115.004316
14. Einstein A.J., Knuuti J. Cardiac imaging: does radiation matter? Eur Heart J. 2012; 33 (5): 573–8. DOI: https://doi.org/10.1093/eurheartj/ehr281
15. Mahesh M., Morin R.L. Radiation exposure and patient dose in cardiology. J Am Coll Radiol. 2017; 14 (12): 1581–2. DOI: https://doi.org/10.1016/j.jacr.2017.09.003
16. Hirshfeld J.W. Jr, Ferrari V.A., Bengel F.M., Bergersen L., Chambers C.E., Einstein A.J., et al. 2018 ACC/HRS/NASCI/SCAI/SCCT expert consensus document on optimal use of ionizing radiation in cardiovascular imaging: best practices for safety and effectiveness. J Am Coll Cardiol. 2018; 71 (24): e283–351. DOI: https://doi.org/10.1016/j.jacc.2018.02.018
17. DePuey E.G. Advances in SPECT camera software and hardware: currently available and new on the horizon. J Nucl Cardiol. 2012; 19: 551–81. DOI: https://doi.org/10.1007/s12350-012-9544-7
18. Ritt P., Vija H., Hornegger J., Kuwert T. Absolute quantification in SPECT. Eur J Nucl Med Mol Imaging. 2011; 38 (suppl 1): S69–77. DOI: https://doi.org/10.1007/s00259-011-1770-8
19. DePuey E.G., Ata P., Wray R., Friedman M. Very low-activity stress/high-activity rest, single-day myocardial perfusion SPECT with a conventional sodium iodide camera and wide beam reconstruction processing. J Nucl Cardiol. 2012; 19: 931–44. DOI:https://doi.org/10.1007/s12350-012-9596-8
20. Lee H., Lee W.W., Park S.Y., Kim S.E. F-18 sodium fluoride positron emission tomography/computed tomography for detection of thyroid cancer bone metastasis compared with bone scintigraphy. Korean J Radiol. 2016; 17: 281–8. DOI: https://doi.org/10.3348/kjr.2016.17.2.281
21. Maiga A.W., Deppen S.A., Mercaldo S.F., et al. Assessment of fluorodeoxyglucose F18-labeled positron emission tomography for diagnosis of high-risk lung nodules. JAMA Surg. 2018; 153 (4): 329–34. DOI: https://doi.org/10.1001/jamasurg.2017.4495
22. Aoyama R., Takano H., Kobayashi Y., et al. Evaluation of myocardial glucose metabolism in hypertrophic cardiomyopathy using 18F-fluorodeoxyglucose positron emission tomography. PLoS One. 2017; 12 (11): e0188479. DOI: https://doi.org/10.1371/journal.pone.0188479
23. Lee W.W., Marinelli B., van der Laan A.M., Sena B.F., Gorbatov R., Leuschner F., et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol. 2012; 59: 153–63. DOI: https://doi.org/10.1016/j.jacc.2011.08.066
24. Kaufmann P.A. Cardiac PET/MR: big footprint-small step? J Nucl Cardiol. 2015; 22: 225–6. DOI:https://doi.org/10.1007/s12350-015-0089-4
25. Lee S.J., Lee W.W., Kim S.E. Bone positron emission tomography with or without CT is more accurate than bone scan for detection of bone metastasis. Korean J Radiol. 2013; 14: 510–9. DOI: https://doi.org/10.3348/kjr.2013.14.3.510
26. Lee H., Lee K.S., Lee W.W. 18F-NaF PET/CT findings in fibrous dysplasia. Clin Nucl Med. 2015; 40: 912–4. DOI: https://doi.org/10.1097/RLU.0000000000000948
27. Irkle A., Vesey A.T., Lewis D.Y., Skepper J.N., Bird J.L., Dweck M.R., et al. Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography. Nat Commun. 2015; 6: 8495. DOI: https://doi.org/10.1038/ncomms8495
28. Fiz F., Morbelli S., Piccardo A., Bauckneht M., Ferrarazzo G., Pestarino E., et al. 18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity. J Nucl Med. 2015; 56: 1019–23. DOI: https://doi.org/10.2967/jnumed.115.154229
29. Joshi N.V., Vesey A.T., Williams M.C., Shah A.S., Calvert P.A., Craighead F.H., et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014; 383: 705–13. DOI: https://doi.org/10.1016/S0140-6736(13)61754-7
30. Seward J.B., Casaclang-Verzosa G. Infiltrative cardiovascular diseases: cardiomyopathies that look alike. J Am Coll Cardiol. 2010; 55 (17): 1769–79. DOI: https://doi.org/10.1016/j.jacc.2009.12.040
31. Bois J.P., Chareonthaitawee P. Optimizing radionuclide imaging in the assessment of cardiac sarcoidosis. J Nucl Cardiol. 2016; 23: 253–5. DOI: https://doi.org/10.1007/s12350-015-0252-y
32. Youssef G., Leung E., Mylonas I., Nery P., Williams K., Wisenberg G., et al. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012; 53: 241–8. DOI: https://doi.org/10.2967/jnumed.111.090662
33. Bokhari S., Castano A., Pozniakoff T., Deslisle S., Latif F., Maurer M.S. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013; 6: 195–201. DOI: https://doi.org/10.1161/CIRCIMAGING.112.000132
34. Van Der Gucht A., Galat A., Rosso J., Guellich A., Garot J., Bodez D., et al. [18F]-NaF PET/CT imaging in cardiac amyloidosis. J Nucl Cardiol. 2016; 23 (4): 846–9. DOI: https://doi.org/10.1007/s12350-015-0287-0
35. Lee S.P., Lee E.S., Choi H., Im H.J., Koh Y., Lee M.H., et al. 11C-Pittsburgh B PET imaging in cardiac amyloidosis. JACC Cardiovasc Imaging. 2015; 8: 50–9. DOI: https://doi.org/10.1016/j.jcmg.2014.09.018